Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions

Table of Contents

February 2006; Volume 50,Issue 2

Clinical Therapeutics

  • Clinical Therapeutics
    Low Levels of Pyrazinamide and Ethambutol in Children with Tuberculosis and Impact of Age, Nutritional Status, and Human Immunodeficiency Virus Infection
    S. M. Graham, D. J. Bell, S. Nyirongo, R. Hartkoorn, S. A. Ward, E. M. Molyneux
  • Clinical Therapeutics
    Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae: Risk Factors, Molecular Epidemiology, and Clinical Outcome
    Mario Tumbarello, Teresa Spanu, Maurizio Sanguinetti, Rita Citton, Eva Montuori, Fiammetta Leone, Giovanni Fadda, Roberto Cauda
  • Clinical Therapeutics
    Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal Infection
    A. J. Ullmann, O. A. Cornely, A. Burchardt, R. Hachem, D. P. Kontoyiannis, K. Töpelt, R. Courtney, D. Wexler, G. Krishna, M. Martinho, G. Corcoran, I. Raad
  • Clinical Therapeutics
    Clinical Evaluation of Macrolide-Resistant Mycoplasma pneumoniae
    Satowa Suzuki, Tsutomu Yamazaki, Mitsuo Narita, Norio Okazaki, Isao Suzuki, Tomoaki Andoh, Mayumi Matsuoka, Tsuyoshi Kenri, Yoshichika Arakawa, Tsuguo Sasaki

Experimental Therapeutics

  • Experimental Therapeutics
    Hexadecylphosphocholine (Miltefosine) Has Broad-Spectrum Fungicidal Activity and Is Efficacious in a Mouse Model of Cryptococcosis
    Fred Widmer, Lesley C. Wright, Daniel Obando, Rosemary Handke, Ranjini Ganendren, David H. Ellis, Tania C. Sorrell
  • Experimental Therapeutics
    Effect of Amphotericin B and Micafungin Combination on Survival, Histopathology, and Fungal Burden in Experimental Aspergillosis in the p47phox−/− Mouse Model of Chronic Granulomatous Disease
    Carly G. Dennis, William R. Greco, Yseult Brun, Richard Youn, Harry K. Slocum, Ralph J. Bernacki, Russell Lewis, Nathan Wiederhold, Steven M. Holland, Ruta Petraitiene, Thomas J. Walsh, Brahm H. Segal
  • Experimental Therapeutics
    Pharmacodynamic Activity of Amphotericin B Deoxycholate Is Associated with Peak Plasma Concentrations in a Neutropenic Murine Model of Invasive Pulmonary Aspergillosis
    Nathan P. Wiederhold, Vincent H. Tam, Jingduan Chi, Randall A. Prince, Dimitrios P. Kontoyiannis, Russell E. Lewis
  • Experimental Therapeutics
    Human Immunoglobulin G Recognizing Fibrinogen-Binding Surface Proteins Is Protective against both Staphylococcus aureus and Staphylococcus epidermidis Infections In Vivo
    John H. Vernachio, Arnold S. Bayer, Brenda Ames, Dawn Bryant, Bradley D. Prater, Peter J. Syribeys, Elena L. Gorovits, Joseph M. Patti
  • Experimental Therapeutics
    Linezolid in Prophylaxis against Experimental Aortic Valve Endocarditis Due to Streptococcus oralis or Enterococcus faecalis
    George Athanassopoulos, Angelos Pefanis, Vissaria Sakka, Dimitrios Iliopoulos, Despina Perrea, Helen Giamarellou
  • Experimental Therapeutics
    Pharmacokinetic-Pharmacodynamic Comparison of Amphotericin B (AMB) and Two Lipid-Associated AMB Preparations, Liposomal AMB and AMB Lipid Complex, in Murine Candidiasis Models
    D. Andes, N. Safdar, K. Marchillo, R. Conklin
  • Experimental Therapeutics
    Efficacy of Quinolones against Secondary Pneumococcal Pneumonia after Influenza Virus Infection in Mice
    Katsuhiko Hayashi, Shin-etsu Kadowaki, Masaya Takei, Hideyuki Fukuda
  • Experimental Therapeutics
    Efficacy of Telavancin against Penicillin-Resistant Pneumococci and Staphylococcus aureus in a Rabbit Meningitis Model and Determination of Kinetic Parameters
    Armin Stucki, Peter Gerber, Fernando Acosta, Marianne Cottagnoud, Philippe Cottagnoud
  • Experimental Therapeutics
    Pulsatile Delivery of Clarithromycin Alone or in Combination with Amoxicillin against Streptococcus pneumoniae
    Kimberly D. Leuthner, Chrissy M. Cheung, Michael J. Rybak

Mechanisms of Resistance

  • Mechanisms of Resistance
    Novel Mechanism of Antibiotic Resistance Originating in Vancomycin-Intermediate Staphylococcus aureus
    Longzhu Cui, Akira Iwamoto, Jian-Qi Lian, Hui-min Neoh, Toshiki Maruyama, Yataro Horikawa, Keiichi Hiramatsu
  • Mechanisms of Resistance
    Mutations Conferring Aminoglycoside and Spectinomycin Resistance in Borrelia burgdorferi
    Daniel Criswell, Virginia L. Tobiason, J. Stephen Lodmell, D. Scott Samuels
  • Mechanisms of Resistance
    Aspergillus fumigatus C-5 Sterol Desaturases Erg3A and Erg3B: Role in Sterol Biosynthesis and Antifungal Drug Susceptibility
    Laura Alcazar-Fuoli, Emilia Mellado, Guillermo Garcia-Effron, Maria J. Buitrago, Jordi F. Lopez, Joan O. Grimalt, J. Manuel Cuenca-Estrella, Juan L. Rodriguez-Tudela
  • Mechanisms of Resistance
    The Two-Component Regulatory System mtrAB Is Required for Morphotypic Multidrug Resistance in Mycobacterium avium
    Gerard A. Cangelosi, Julie S. Do, Robert Freeman, John G. Bennett, Makeda Semret, Marcel A. Behr
  • Mechanisms of Resistance
    Malaria Parasites Can Develop Stable Resistance to Artemisinin but Lack Mutations in Candidate Genes atp6 (Encoding the Sarcoplasmic and Endoplasmic Reticulum Ca2+ ATPase), tctp, mdr1, and cg10
    A. Afonso, P. Hunt, S. Cheesman, A. C. Alves, C. V. Cunha, V. do Rosário, P. Cravo
  • Mechanisms of Resistance
    Diagnostic PCR Analysis of the Occurrence of Methicillin and Tetracycline Resistance Genes among Staphylococcus aureus Isolates from Phase 3 Clinical Trials of Tigecycline for Complicated Skin and Skin Structure Infections
    C. Hal Jones, Margareta Tuckman, Anita Y. M. Howe, Mark Orlowski, Stanley Mullen, Karen Chan, Patricia A. Bradford
  • Mechanisms of Resistance
    Inhibition of the Autolytic System by Vancomycin Causes Mimicry of Vancomycin-Intermediate Staphylococcus aureus-Type Resistance, Cell Concentration Dependence of the MIC, and Antibiotic Tolerance in Vancomycin-Susceptible S. aureus
    Krzysztof Sieradzki, Alexander Tomasz
  • Mechanisms of Resistance
    Horizontal Transfer of blaCMY-Bearing Plasmids among Clinical Escherichia coli and Klebsiella pneumoniae Isolates and Emergence of Cefepime-Hydrolyzing CMY-19
    Jun-ichi Wachino, Hiroshi Kurokawa, Satowa Suzuki, Kunikazu Yamane, Naohiro Shibata, Kouji Kimura, Yasuyoshi Ike, Yoshichika Arakawa
  • Mechanisms of Resistance
    Fluconazole Treatment Is Effective against a Candida albicans erg3/erg3 Mutant In Vivo Despite In Vitro Resistance
    Taiga Miyazaki, Yoshitsugu Miyazaki, Koichi Izumikawa, Hiroshi Kakeya, Shunichi Miyakoshi, John E. Bennett, Shigeru Kohno
  • Mechanisms of Resistance
    In Vivo Transfer of the vanA Resistance Gene from an Enterococcus faecium Isolate of Animal Origin to an E. faecium Isolate of Human Origin in the Intestines of Human Volunteers
    Camilla H. Lester, Niels Frimodt-Møller, Thomas Lund Sørensen, Dominique L. Monnet, Anette M. Hammerum
  • Mechanisms of Resistance
    Role of the Extended α4 Domain of Staphylococcus aureus Gyrase A Protein in Determining Low Sensitivity to Quinolones
    Jacob Strahilevitz, Ari Robicsek, David C. Hooper
  • Mechanisms of Resistance
    Emergence of DHA-1-Producing Klebsiella spp. in the Parisian Region: Genetic Organization of the ampC and ampR Genes Originating from Morganella morganii
    Charlotte Verdet, Yahia Benzerara, Valérie Gautier, Olivier Adam, Zahia Ould-Hocine, Guillaume Arlet
  • Mechanisms of Resistance
    CMY-16, a Novel Acquired AmpC-Type β-Lactamase of the CMY/LAT Lineage in Multifocal Monophyletic Isolates of Proteus mirabilis from Northern Italy
    Marco M. D'Andrea, Elisabetta Nucleo, Francesco Luzzaro, Tommaso Giani, Roberta Migliavacca, Francesca Vailati, Vesselina Kroumova, Laura Pagani, Gian Maria Rossolini
  • Mechanisms of Resistance
    Involvement of the Putative ATP-Dependent Efflux Proteins PatA and PatB in Fluoroquinolone Resistance of a Multidrug-Resistant Mutant of Streptococcus pneumoniae
    Estelle Marrer, Karen Schad, Andreas T. Satoh, Malcolm G. P. Page, Maggie M. Johnson, Laura J. V. Piddock
  • Mechanisms of Resistance
    Distribution of Tetracycline Resistance Genes in Actinobacillus pleuropneumoniae Isolates from Spain
    Mónica Blanco, César B. Gutiérrez-Martin, Elías F. Rodríguez-Ferri, Marilyn C. Roberts, Jesús Navas
  • Mechanisms of Resistance
    Prediction of the Evolution of Ceftazidime Resistance in Extended-Spectrum β-Lactamase CTX-M-9
    J. Delmas, F. Robin, F. Carvalho, C. Mongaret, R. Bonnet
  • Mechanisms of Resistance
    Occurrence of OXA-58-Like Carbapenemases in Acinetobacter spp. Collected over 10 Years in Three Continents
    Juliana Coelho, Neil Woodford, Mariya Afzal-Shah, David Livermore
  • Mechanisms of Resistance
    Single- and Multistep Resistance Selection Studies on the Activity of Retapamulin Compared to Other Agents against Staphylococcus aureus and Streptococcus pyogenes
    Klaudia Kosowska-Shick, Catherine Clark, Kim Credito, Pamela McGhee, Bonifacio Dewasse, Tatiana Bogdanovich, Peter C. Appelbaum
  • Mechanisms of Resistance
    New TEM-Derived Extended-Spectrum β-Lactamase and Its Genomic Context in Plasmids from Salmonella enterica Serovar Derby Isolates from Uruguay
    Rafael Vignoli, Nicolas F. Cordeiro, Virginia García, María Inés Mota, Laura Betancor, Pablo Power, José A. Chabalgoity, Felipe Schelotto, Gabriel Gutkind, Juan A. Ayala
  • Mechanisms of Resistance
    Emergence of Enterobacteriaceae Isolates Producing CTX-M Extended-Spectrum β-Lactamase in Austria
    Alexandra Eisner, Elizabeth J. Fagan, Gebhard Feierl, Harald H. Kessler, Egon Marth, David M. Livermore, Neil Woodford
  • Mechanisms of Resistance
    PCR Classification of CTX-M-Type β-Lactamase Genes Identified in Clinically Isolated Gram-Negative Bacilli in Japan
    Naohiro Shibata, Hiroshi Kurokawa, Yohei Doi, Tetsuya Yagi, Kunikazu Yamane, Jun-ichi Wachino, Satowa Suzuki, Kouji Kimura, Satoshi Ishikawa, Haru Kato, Yoshiyuki Ozawa, Keigo Shibayama, Kumiko Kai, Toshifumi Konda, Yoshichika Arakawa
  • Mechanisms of Resistance
    In117, an Unusual In0-Like Class 1 Integron Containing CR1 and blaCTX-M-2 and Associated with a Tn21-Like Element
    Aránzazu Valverde, Rafael Cantón, Juan Carlos Galán, Patrice Nordmann, Fernando Baquero, Teresa M. Coque
  • Mechanisms of Resistance
    Streptococcus pyogenes Isolates with High-Level Macrolide Resistance and Reduced Susceptibility to Telithromycin Associated with 23S rRNA Mutations
    David J. Farrell, Jemma Shackcloth, Karen A. Barbadora, Michael D. Green

Mechanisms of Action

  • Mechanisms of Action: Physiological Effects
    Rifalazil Pretreatment of Mammalian Cell Cultures Prevents Subsequent Chlamydia Infection
    Robert J. Suchland, Kara Brown, David M. Rothstein, Walter E. Stamm
  • Mechanisms of Action: Physiological Effects
    Antibacterial Properties of Dermaseptin S4 Derivatives under Extreme Incubation Conditions
    Tali Rydlo, Shahar Rotem, Amram Mor
  • Mechanisms of Action: Physiological Effects
    Discovery of FabH/FabF Inhibitors from Natural Products
    Katherine Young, Hiranthi Jayasuriya, John G. Ondeyka, Kithsiri Herath, Chaowei Zhang, Srinivas Kodali, Andrew Galgoci, Ronald Painter, Vickie Brown-Driver, Robert Yamamoto, Lynn L. Silver, Yingcong Zheng, Judith I. Ventura, Janet Sigmund, Sookhee Ha, Angela Basilio, Francisca Vicente, José Rubén Tormo, Fernando Pelaez, Phil Youngman, Doris Cully, John F. Barrett, Dennis Schmatz, Sheo B. Singh, Jun Wang
  • Mechanisms of Action: Physiological Effects
    Influence of Apigenin on gtf Gene Expression in Streptococcus mutans UA159
    Hyun Koo, Jennifer Seils, Jacqueline Abranches, Robert A. Burne, William H. Bowen, Robert G. Quivey
  • Mechanisms of Action: Physiological Effects
    3,5-Dioxopyrazolidines, Novel Inhibitors of UDP-N- Acetylenolpyruvylglucosamine Reductase (MurB) with Activity against Gram-Positive Bacteria
    Youjun Yang, Anatoly Severin, Rajiv Chopra, Girija Krishnamurthy, Guy Singh, William Hu, David Keeney, Kristine Svenson, Peter J. Petersen, Pornpen Labthavikul, David M. Shlaes, Beth A. Rasmussen, Amedeo A. Failli, Jay S. Shumsky, Kristina M. K. Kutterer, Adam Gilbert, Tarek S. Mansour
  • Mechanisms of Action: Physiological Effects
    Loss of the Homotypic Fusion and Vacuole Protein Sorting or Golgi-Associated Retrograde Protein Vesicle Tethering Complexes Results in Gentamicin Sensitivity in the Yeast Saccharomyces cerevisiae
    Mark C. Wagner, Elizabeth E. Molnar, Bruce A. Molitoris, Mark G. Goebl
  • Mechanisms of Action: Physiological Effects
    Quinolones Induce Partial or Total Loss of Pathogenicity Islands in Uropathogenic Escherichia coli by SOS-Dependent or -Independent Pathways, Respectively
    S. M. Soto, M. T. Jimenez de Anta, J. Vila
  • Mechanisms of Action: Physiological Effects
    Rational Design of Anticytoadherence Inhibitors for Plasmodium falciparum Based on the Crystal Structure of Human Intercellular Adhesion Molecule 1
    Matthias Dormeyer, Yvonne Adams, Bernd Kramer, Srabasti Chakravorty, Man Tsuey Tse, Stefano Pegoraro, Lisa Whittaker, Michael Lanzer, Alister Craig
  • Mechanisms of Action: Physiological Effects
    Doxycycline Attenuated Pulmonary Fibrosis Induced by Bleomycin in Mice
    Masaki Fujita, Qing Ye, Hiroshi Ouchi, Eiji Harada, Ichiro Inoshima, Kazuyoshi Kuwano, Yoichi Nakanishi
  • Mechanisms of Action: Physiological Effects
    Inhibition of Candida parapsilosis Mitochondrial Respiratory Pathways Enhances Susceptibility to Caspofungin
    Georgios Chamilos, Russell E. Lewis, Dimitrios P. Kontoyiannis
  • Mechanisms of Action: Physiological Effects
    Trematocidal Activity of Praziquantel and Artemisinin Derivatives: In Vitro and In Vivo Investigations with Adult Echinostoma caproni
    Jennifer Keiser, Reto Brun, Bernard Fried, Jürg Utzinger
  • Mechanisms of Action: Physiological Effects
    Piperine, a Phytochemical Potentiator of Ciprofloxacin against Staphylococcus aureus
    Inshad Ali Khan, Zahid Mehmood Mirza, Ashwani Kumar, Vijeshwar Verma, Ghulam Nabi Qazi

Chemistry; Biosynthesis

  • Chemistry; Biosynthesis
    Novel Compounds Active against Leishmania major
    Stephanie St. George, Jeanette V. Bishop, Richard G. Titus, Claude P. Selitrennikoff

Antiviral Agents

  • Antiviral Agents
    Inhibition of Human Immunodeficiency Virus Type 1 Replication in Latently Infected Cells by a Novel IκB Kinase Inhibitor
    Ann Florence B. Victoriano, Kaori Asamitsu, Yurina Hibi, Kenichi Imai, Nina G. Barzaga, Takashi Okamoto
  • Antiviral Agents
    Novel Yeast Cell-Based Assay To Screen for Inhibitors of Human Cytomegalovirus Protease in a High-Throughput Format
    Valérie Cottier, Alcide Barberis, Urs Lüthi
  • Antiviral Agents
    In Vitro Antiretroviral Activity and In Vitro Toxicity Profile of SPD754, a New Deoxycytidine Nucleoside Reverse Transcriptase Inhibitor for Treatment of Human Immunodeficiency Virus Infection
    Z. Gu, B. Allard, J. M. de Muys, J. Lippens, R. F. Rando, N. Nguyen-Ba, C. Ren, P. McKenna, D. L. Taylor, R. C. Bethell
  • Antiviral Agents
    Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent
    Joke Snoeck, Rami Kantor, Robert W. Shafer, Kristel Van Laethem, Koen Deforche, Ana Patricia Carvalho, Brian Wynhoven, Marcelo A. Soares, Patricia Cane, John Clarke, Candice Pillay, Sunee Sirivichayakul, Koya Ariyoshi, Africa Holguin, Hagit Rudich, Rosangela Rodrigues, Maria Belen Bouzas, Françoise Brun-Vézinet, Caroline Reid, Pedro Cahn, Luis Fernando Brigido, Zehava Grossman, Vincent Soriano, Wataru Sugiura, Praphan Phanuphak, Lynn Morris, Jonathan Weber, Deenan Pillay, Amilcar Tanuri, Richard P. Harrigan, Ricardo Camacho, Jonathan M. Schapiro, David Katzenstein, Anne-Mieke Vandamme
  • Antiviral Agents
    In Vitro Preclinical Testing of Nonoxynol-9 as Potential Anti-Human Immunodeficiency Virus Microbicide: a Retrospective Analysis of Results from Five Laboratories
    Brigitte E. Beer, Gustavo F. Doncel, Fred C. Krebs, Robin J. Shattock, Patricia S. Fletcher, Robert W. Buckheit, Karen Watson, Charlene S. Dezzutti, James E. Cummins, Ena Bromley, Nicola Richardson-Harman, Luke A. Pallansch, Carol Lackman-Smith, Clay Osterling, Marie Mankowski, Shendra R. Miller, Bradley J. Catalone, Patricia A. Welsh, Mary K. Howett, Brian Wigdahl, Jim A. Turpin, Patricia Reichelderfer
  • Antiviral Agents
    A Porphyrin Increases Survival Time of Mice after Intracerebral Prion Infection
    David A. Kocisko, Winslow S. Caughey, Richard E. Race, Grant Roper, Byron Caughey, John D. Morrey
  • Antiviral Agents
    Practical Preclinical Model for Assessing the Potential for Unconjugated Hyperbilirubinemia Produced by Human Immunodeficiency Virus Protease Inhibitors
    Dale J. Kempf, Jeffrey F. Waring, David C. Morfitt, Paige Werner, Brian Ebert, Michael Mitten, Bach Nguyen, John T. Randolph, David A. DeGoey, Larry L. Klein, Kennan Marsh
  • Antiviral Agents
    Effect of Ribavirin and Glucocorticoid Treatment in a Mouse Model of Human Metapneumovirus Infection
    Marie-Ève Hamelin, Gregory A. Prince, Guy Boivin

Susceptibility

  • Susceptibility
    Nonmolecular Test for Detection of Low-Level Resistance to Fluoroquinolones in Streptococcus pneumoniae
    Emmanuelle Varon, Serge Houssaye, Sophie Grondin, Laurent Gutmann
    and the Groupe des Observatoires de la Résistance du Pneumocoque
  • Susceptibility
    Potencies of Human Immunodeficiency Virus Protease Inhibitors In Vitro against Plasmodium falciparum and In Vivo against Murine Malaria
    Katherine T. Andrews, David P. Fairlie, Praveen K. Madala, John Ray, David M. Wyatt, Petrina M. Hilton, Lewis A. Melville, Lynette Beattie, Donald L. Gardiner, Robert C. Reid, Martin J. Stoermer, Tina Skinner-Adams, Colin Berry, James S. McCarthy
  • Susceptibility
    Potentiation of Catechin Gallate-Mediated Sensitization of Staphylococcus aureus to Oxacillin by Nongalloylated Catechins
    Paul D. Stapleton, Saroj Shah, Yukihiko Hara, Peter W. Taylor
  • Susceptibility
    Antimicrobial Susceptibilities of Campylobacter jejuni Isolates from Poultry from Alberta, Canada
    Veronica N. Kos, Monika Keelan, Diane E. Taylor
  • Susceptibility
    In Vitro Activity of DX-619, a Novel Des-Fluoro(6) Quinolone, against a Panel of Streptococcus pneumoniae Mutants with Characterized Resistance Mechanisms
    Paul A. Wickman, Ellen Smith Moland, Jennifer A. Black, Kenneth S. Thomson
  • Susceptibility
    In Vitro Bactericidal Activity of Human β-Defensin 3 against Multidrug-Resistant Nosocomial Strains
    Giuseppantonio Maisetta, Giovanna Batoni, Semih Esin, Walter Florio, Daria Bottai, Flavia Favilli, Mario Campa
  • Susceptibility
    In Vitro Activity of Doripenem against Pseudomonas aeruginosa and Burkholderia cepacia Isolates from both Cystic Fibrosis and Non-Cystic Fibrosis Patients
    M. M. Traczewski, S. D. Brown

Pharmacology

  • Pharmacology
    Safety and Pharmacokinetics of Intravenous Anidulafungin in Children with Neutropenia at High Risk for Invasive Fungal Infections
    Daniel K. Benjamin, Timothy Driscoll, Nita L. Seibel, Corina E. Gonzalez, Maureen M. Roden, Rahki Kilaru, Kay Clark, James A. Dowell, Jennifer Schranz, Thomas J. Walsh
  • Pharmacology
    Pharmacokinetics of Enfuvirtide in Patients Treated in Typical Routine Clinical Settings
    Hartmut Stocker, Charlotte Kloft, Nele Plock, Antje Breske, Guido Kruse, Christian Herzmann, Hubert Schulbin, Peter Kreckel, Christoph Weber, Frank Goebel, Joerg Roeling, Schlomo Staszewski, Andreas Plettenberg, Christiane Moecklinghoff, Keikawus Arastéh, Michael Kurowski
  • Pharmacology
    Tissue Penetration of Telavancin after Intravenous Administration in Healthy Subjects
    Heather K. Sun, Kenneth Duchin, Charles H. Nightingale, Jeng-Pyng Shaw, Julie Seroogy, David P. Nicolau

Letters

  • LETTERS TO THE EDITOR
    Evaluation of High- versus Standard-Dose Rifampin in Indonesian Patients with Pulmonary Tuberculosis
    Rovina Ruslami, Hanneke Nijland, Rob Aarnoutse, Bachti Alisjahbana, Arto Yuwono Soeroto, Suzanne Ewalds, Reinout van Crevel
  • LETTERS TO THE EDITOR
    Tularemia and Once-Daily Gentamicin
    Ali Hassoun, Richard Spera, John Dunkel
  • LETTERS TO THE EDITOR
    In Vitro Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii
    D. W. Wareham, D. C. Bean
PreviousNext
Back to top

Antimicrobial Agents and Chemotherapy: 50 (2)

In This Issue

volume 50, issue 2
  • Table of Contents (PDF)
  • Masthead (PDF)
Sign up for alerts

Jump to

  • Clinical Therapeutics
  • Experimental Therapeutics
  • Mechanisms of Resistance
  • Mechanisms of Action
  • Chemistry; Biosynthesis
  • Antiviral Agents
  • Susceptibility
  • Pharmacology
  • Letters
  • Most Read
  • Most Cited
Loading
  • Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2
  • Mechanism-of-Action Classification of Antibiotics by Global Transcriptome Profiling
  • Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions
  • Povidone Iodine: Properties, Mechanisms of Action, and Role in Infection Control and Staphylococcus aureus Decolonization
More...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596